Alyeska Investment Group
CLVS

Alyeska Investment Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Alyeska Investment Group’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-385,403
Closed -$1.51M – 512
2019
Q3 		$1.51M Buy
385,403
+67,257
+21% +$544K 0.02% 308
2019
Q2 		$4.73M Buy
318,146
+150,039
+89% +$2.71M 0.06% 242
2019
Q1 		$4.17M Buy
+168,107
New +$4.21M 0.06% 236
2018
Q4 		– Sell
-79,549
Closed -$2.34M – 493
2018
Q3 		$2.34M Buy
79,549
+2,071
+3% +$80.2K 0.03% 293
2018
Q2 		$3.52M Buy
+77,478
New +$3.77M 0.03% 303

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Alyeska Investment Group's CLVS Position: Q4 2019 in Review

Alyeska Investment Group sold out of Clovis Oncology, Inc. (CLVS) in Q4 2019, closing a stake of 385,403 shares — an estimated $1.51M sold.

Alyeska Investment Group first reported a position in CLVS in Q2 2018 and held it in 5 quarters. The position peaked at $4.73M in Q2 2019. 147 funds tracked by Wall St. Rank hold CLVS as of Q4 2019.

  • Alyeska Investment Group reported no remaining Clovis Oncology, Inc. position as of Q4 2019 after selling out during the quarter.
  • Alyeska Investment Group sold 385,403 Clovis Oncology, Inc. shares in Q4 2019, an estimated $1.51M.
  • Alyeska Investment Group first reported a position in Clovis Oncology, Inc. in Q2 2018 and held it in 5 quarters.
  • Alyeska Investment Group's Clovis Oncology, Inc. position peaked at $4.73M in Q2 2019.
  • 147 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2019.

Based on Alyeska Investment Group's 13F filing for Q4 2019, filed 14 Feb 2020.